Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2022/01/039863
CTRI/2022/01/039863
Completed
Phase 2

Preclinical and clinical evaluation of the effect on oral administration of KARUNJEERAKA MATHIRAI along with external application of NUNAA TAILAM in the management of VENPADAI in children

Dr S Surendar0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr S Surendar
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Dr S Surendar

Eligibility Criteria

Inclusion Criteria

  • •1\.Hypo pigemented patches surrounded by hyper pigemneted border present in any part of the body

Exclusion Criteria

  • •1\.Children above 12 years
  • •2\.Children below 3 years
  • •3\.Albinism
  • •4\.Pie\-baldism
  • •5\.Hypo pigmented patches start firstly in lips and genital area
  • •6\.Depigemented patches after burns
  • •7\.Juvenile diabetes with vitiligo

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 2
Preclinical and Clinical evaluation of the effect on oral administration of PARANGI KASAYAM along with external application of VARMAM THERAPHY in the management of INFANTILE HEMIPLEGIA in childreHealth Condition 1: G819- Hemiplegia, unspecified
CTRI/2022/11/046972DR M MUKILA
Completed
Phase 2
Preclinical and clinical evaluation of the effect of siddha classical drug MANITHAKKALI ENNAI (oral administration) in the management of VITAMIN -B COMPLEX DEFICIENCYHealth Condition 1: E539- Vitamin B deficiency, unspecified
CTRI/2022/02/039956Dr S Aiswarya40
Completed
Phase 2
Preclinical and clinical evaluation of the effect of Siddha classical drug GANTHAGA NEI(oral administration) along with NATHTHAICHOORI TAILAM(external therapy) in the management of CEREBRAL PALSY.Health Condition 1: G801- Spastic diplegic cerebral palsyHealth Condition 2: G802- Spastic hemiplegic cerebral palsy
CTRI/2022/06/043082Dr P RAJAVATHANA40
Active, not recruiting
Phase 2
Preclinical and clinical evaluation of siddha classical drug MEDATHAARI CHOORANAM (oral administration) and CHITHIRAMOOLA TAILAM (external) in the management of JUVENILE ARTHRITIS.
CTRI/2022/01/039856Dr P Ponsridharani
Completed
Phase 2
Preclinical and clinical evaluation of the effect of Siddha classical drug PARUMA NOI NIVARANA MAATHIRAI & NEERMULLI OORAL KUDINEER (oral administration ) along with PODI THIMIRTHAL ( external therapy) in the management of CHILDHOOD OBESITY.Health Condition 1: E65- Localized adiposityHealth Condition 2: E660- Obesity due to excess caloriesHealth Condition 3: E663- Overweight
CTRI/2022/02/040297Dr J Mangalavalli40